Department of Science appoints a committee Gathering various experts with “Doctor Yong” to test the effectiveness of the smallpox vaccine of the Government Pharmaceutical Organization. preserved for more than 40 years, initially effective The trend is good. Wait 2 more weeks for contaminant test results.
Dr. Supakit Sirilak, Director-General of the Department of Medical Sciences Reveal the progress of the inspection of the smallpox vaccine that the Pharmaceutical Organization (GPO) kept frozen and preserved. After 1980, when the smallpox epidemic ended, the smallpox vaccination was canceled or the vaccination was canceled, saying that the vaccine was powdered. (Dry freeze) There are 10,000 Vials in 13 lots. In 1 vial can be injected 50 doses, calculated to be approximately 500,000 doses. Preliminary at the Department of Medical Sciences brought to test the efficiency, the results appear to be able to recover well and works well This smallpox vaccine is made from the bovine smallpox vaccine. which is a weak infection It is the first vaccine. The form of use will poke the skin into a wound and tap the vaccine powder on it. It will form an abscess and become dry flakes, then it will build immunity in the body. While the current smallpox vaccine is administered by injection into the skin,
Dr. Supakit also said that a committee has now been set up. Presided over by Prof. Dr. Yong Phuworawan, head of the Center specializing in clinical virology. Faculty of Medicine Chulalongkorn University Including representatives from the Pharmaceutical Organization (GPO) came together to help test the vaccine more that in 1 vial with 50 doses, the 50 doses are still effective or not. Looks like it’s likely to yield good results. The second part must be checked for contaminants. Is there any mold or fungus? Since it has been stored for more than 40 years, there is no problem expected since it is a dry powder packed in a sealed glass jar. Including having to check all 13 stored lots. Expect it to take another 2 weeks for the results to be known.
Dr. Supakit said that the first version of this vaccine will be able to develop a model for use as the third generation or not. However, with the monkey pox situation now it seems likely that there will be no serious problems. Because the infection is quite difficult, it must be through close contact with the child to the person. But we do not underestimate at least we have in hand 5 hundred thousand doses, if there is a risk, would not inject general. would consider only those at risk of being infected The side effects of this vaccine Because it was used 40 years ago and the technology has not advanced as it is today. As has been reported, it has caused myocarditis. meningitis, but very rarely
* can follow And share Hfocus news at https://www.facebook.com/Hfocus.org